These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12699840)

  • 1. The initial course of in-stent restenosis influences the response to vascular brachytherapy.
    Cheneau E; Leborgne L; Wolfram R; Dilcher C; Pakala R; Pichard AD; Satler LF; Canos D; Lindsay J; Waksman R
    Cardiovasc Radiat Med; 2002; 3(2):102-6. PubMed ID: 12699840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.
    Negi SI; Torguson R; Gai J; Kiramijyan S; Koifman E; Chan R; Randolph P; Pichard A; Satler LF; Waksman R
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1259-1265. PubMed ID: 27339842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series.
    Almeda FQ; Nambiar R; Chua DC; Senter S; Haynie J; Kavinsky CJ; Snell J; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(4):162-5. PubMed ID: 16237984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes.
    Benjo A; Cardoso RN; Collins T; Garcia D; Macedo FY; El-Hayek G; Nadkarni G; Aziz E; Jenkins JS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):200-8. PubMed ID: 25963829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Vascular Brachytherapy and Stenting for the Treatment of In-Stent Restenosis.
    Chen Y; Buchanan KD; Chan RC; Zhang C; Torguson R; Satler LF; Waksman R
    Am J Cardiol; 2020 Mar; 125(5):712-719. PubMed ID: 31889523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis.
    Schukro C; Syeda B; Schmid R; Stemberger A; Lang I; Derntl M; Neunteufl T; Christ G; Kirisits C; Pokrajac B; Glogar D
    Coron Artery Dis; 2004 Aug; 15(5):285-9. PubMed ID: 15238826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial intravascular ultrasound analysis after intracoronary beta-radiation in long in-stent restenotic lesions.
    Schiele TM; Zimmermann A; Rieber J; König A; Krötz F; Sohn HY; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Bauriedel G; Klauss V
    Z Kardiol; 2002; 91 Suppl 3():17-22. PubMed ID: 12641011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
    Alli OO; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; Holmes DR;
    Am Heart J; 2012 Mar; 163(3):438-45. PubMed ID: 22424015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Omer M; Willson L; Monyak DJ; Sullivan P; Stanberry L; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Cardiovasc Revasc Med; 2021 Jan; 22():29-33. PubMed ID: 32571761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Patients With Recurrent Coronary In-stent Restenosis With Failed Intravascular Brachytherapy.
    Yerasi C; Chen Y; Case BC; Forrestal BJ; Shea C; Zhang C; Torguson R; Ben-Dor I; Satler LF; Waksman R
    Am J Cardiol; 2021 Mar; 142():44-51. PubMed ID: 33285089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.
    Ribichini F; Ferrero V; Piessens M; Heyndrickx GR; de Bruyne B; Verbeke L; Matullo G; Büchi M; Piazza A; Guarrera S; Lüscher TF; Wijns W
    Cardiovasc Revasc Med; 2005; 6(1):7-13. PubMed ID: 16263350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
    Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
    Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.